Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1980 Apr 5;280(6219):982–983. doi: 10.1136/bmj.280.6219.982

Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs.

R Enat, S Pollack, Y Ben-Arieh, E Livni, D Barzilai
PMCID: PMC1601139  PMID: 7417768

Abstract

Severe intrahepatic cholestasis occurred in a patient after taking nitrofurantoin, ampicillin, and cloxacillin. As only nitrofurantoin was known to cause cholestasis she was given cloxacillin again two years later. The cholestasis reappeared at once. A macrophage inhibition factor test confirmed that cloxacillin was the offending drug. Cloxacillin should be added to the growing list of drugs causing cholestasis. Inadvertent rechallenge with hepatototoxic drugs might be prevented by routine use of the macrophage inhibition factor test.

Full text

PDF
982

Images in this article

982p982-a
on p.982

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Whitecar J. P., Jr, Middleman E., Rodriguez V. Carbenicillin therapy for pseudomonas infections. JAMA. 1971 Oct 4;218(1):62–66. [PubMed] [Google Scholar]
  2. Bruckstein A. H., Attia A. A. Oxacillin hepatitis. Two patients with liver biopsy, and review of the literature. Am J Med. 1978 Mar;64(3):519–522. doi: 10.1016/0002-9343(78)90246-2. [DOI] [PubMed] [Google Scholar]
  3. Dismukes W. E. Oxacillin-induced hepatic dysfunction. JAMA. 1973 Nov 19;226(8):861–863. [PubMed] [Google Scholar]
  4. Enat R., Barzilai D., Gellei B. Hepatic injury due to pyridinol carbamate. Isr J Med Sci. 1978 Mar;14(3):333–338. [PubMed] [Google Scholar]
  5. Girard J. P., Haenni B., Bergoz R., Kapanci Y., Cruchaud A. Lupoid hepatitis following administration of penicillin. Case report and immunological studies. Helv Med Acta. 1967 Dec;34(1):23–35. [PubMed] [Google Scholar]
  6. Goldstein L. I., Ishak K. G. Hepatic injury associated with penicillin therapy. Arch Pathol. 1974 Aug;98(2):114–117. [PubMed] [Google Scholar]
  7. Gump D. W. Elevated SGOT levels after carbenicillin. N Engl J Med. 1970 Jun 25;282(26):1489–1490. doi: 10.1056/NEJM197006252822614. [DOI] [PubMed] [Google Scholar]
  8. HUANG N. N., SPROUL A., PROMADHATTAVEDI V., HIGH R. H. LONG-TERM THERAPY WITH OXACILLIN IN PATIENTS WITH CYSTIC FIBROSIS. Antimicrob Agents Chemother (Bethesda) 1963;161:237–242. [PubMed] [Google Scholar]
  9. Klein I., Tobias H. Oxacillin-associated hepatitis. Am J Gastroenterol. 1976 Jun;65(6):546–546. [PubMed] [Google Scholar]
  10. Knirsch A. K., Gralla E. J. Abnormal serum transaminase levels after parenteral ampicillin and carbenicillin administration. N Engl J Med. 1970 May 7;282(19):1081–1082. doi: 10.1056/NEJM197005072821907. [DOI] [PubMed] [Google Scholar]
  11. Kuritzky A., Livni E., Munitz H., Englander T., Tyano S., Wijsenbeek H., Joshua H., Kott E. Cell-mediated immunity to human myelin basic protein in schizophrenic patients. J Neurol Sci. 1976 Dec;30(2-3):369–373. doi: 10.1016/0022-510x(76)90140-4. [DOI] [PubMed] [Google Scholar]
  12. Nelson J. D., Haltalin K. C. Broad-spectrum penicillins in enteric infections of children. Ann N Y Acad Sci. 1967 Sep 27;145(2):414–422. doi: 10.1111/j.1749-6632.1967.tb50240.x. [DOI] [PubMed] [Google Scholar]
  13. Neu H. C., Swarz H. Carbenicillin: clinical and laboratory experience with a parenterally administered penicillin for treatment of Pseudomonas infections. Ann Intern Med. 1969 Nov;71(5):903–911. doi: 10.7326/0003-4819-71-5-903. [DOI] [PubMed] [Google Scholar]
  14. Onorato I. M., Axelrod J. L. Hepatitis from intravenous high-dose oxacillin therapy: findings in an adult inpatient population. Ann Intern Med. 1978 Oct;89(4):497–500. doi: 10.7326/0003-4819-89-4-497. [DOI] [PubMed] [Google Scholar]
  15. PAS A. T., QUINN E. L. CHOLESTATIC HEPATITIS FOLLOWING THE ADMINISTRATION OF SODIUM OXACILLIN. JAMA. 1965 Feb 22;191:674–675. doi: 10.1001/jama.1965.03080080064024. [DOI] [PubMed] [Google Scholar]
  16. Perez V., Schaffner F., Popper H. Hepatic drug reactions. Prog Liver Dis. 1972;4:597–625. [PubMed] [Google Scholar]
  17. Pollock A. A., Berger S. A., Simberkoff M. S., Rahal J. J., Jr Hepatitis associated with high-dose oxacillin therapy. Arch Intern Med. 1978 Jun;138(6):915–917. [PubMed] [Google Scholar]
  18. Rajapakse D. A., Glynn L. E. Macrophage migration inhibition test using guinea-pig macrophages and human lymphocytes. Nature. 1970 May 30;226(5248):857–858. doi: 10.1038/226857a0. [DOI] [PubMed] [Google Scholar]
  19. SUMMERSKILL W. H. THE SYNDROME OF BENIGN RECURRENT CHOLESTASIS. Am J Med. 1965 Feb;38:298–305. doi: 10.1016/0002-9343(65)90184-1. [DOI] [PubMed] [Google Scholar]
  20. Walker S. H., Standiford W. E. The treatment of infants with oxacillin sodium. Am J Dis Child. 1967 Jul;114(1):64–68. doi: 10.1001/archpedi.1967.02090220070012. [DOI] [PubMed] [Google Scholar]
  21. Wilson F. M., Belamaric J., Lauter C. B., Lerner A. M. Anicteric carbenicillin hepatitis. Eight episodes in four patients. JAMA. 1975 May 26;232(8):818–821. doi: 10.1001/jama.232.8.818. [DOI] [PubMed] [Google Scholar]
  22. Zimmerman H. J. Liver disease caused by medicinal agents. Med Clin North Am. 1975 Jul;59(4):897–907. doi: 10.1016/s0025-7125(16)31988-5. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES